奥曲肽治疗急性水肿型胰腺炎患者临床疗效分析

目的探讨奥曲肽治疗急性水肿型胰腺炎的临床疗效情况。方法选取2010年1月-2012年10月收治的急性水肿型胰腺炎患者120例,采取电脑分组的方法分成观察组、对照组各60例,对照组给予常规治疗,观察组在常规治疗基础上给予奥曲肽治疗,比较两组患者的临床疗效。结果观察组疗效优35例,疗效良20例,疗效中3例,疗效差2例,疗效优良率为91.67%;对照组疗效优9例,疗效良37例,疗效中9例,疗效差5例,疗效优良率为76.67%。观察组临床疗效显著高于对照组,P〈0.05,具有统计学意义。治疗后,观察组患者各项临床指标情况显著优于对照组,并均具有显著性差异,P〈0.05。结论急性水肿型胰腺炎患者在常规治疗基础上给予奥曲肽治疗,可以显著提高临床疗效,值得临床进一步推广。

Analysis of clinical efficacy of octreotide treatment of acute edematous pancreatitis

Objective ] To investigate the clinical efficacy of octreotide in the treatment of acute edematous pancreatitis. Methods ] 120 patients with acute edematous pancreatitis from January 2010 to October 2012 were cases, adopt the method of computer group divided into the observation group, the control group with 60 cases in each group, the control group was given conventional treatment, the observation group in the conventional treatment on the basis of given octreotide treatment, compared two groups of patients with clinical curative effect. Results ] The curative effect of therapeutic group were excellent in 35 cases, good in 20 cases clinical curative effect, 3 cases, poor effect in 2 cases, the excellent and good rate was 91.67%; the control group 9 cases of good therapeutic efficacy, efficacy good in 37 cases, curative effect in 9 cases, poor effect in 5 cases, the excellent and good rate was 76.67%. To observe the clinical efficacy was significantly higher than that in control group, P〈0.05, with statistical significance. After treatment, the patients in observation group clinical indicators were significantly better than the control group, and were significant difference, P〈0.05. Conclusion ] For patients with acute edematous pancreatitis treated with octreotide on the basis of conventional therapy, can significantly improve the clinical efficacy, is worthy of further promotion.